Annual EBITDA
-$31.62 M
-$18.64 M-143.67%
December 31, 2022
Summary
- As of February 10, 2025, APEN annual EBITDA is -$31.62 million, with the most recent change of -$18.64 million (-143.67%) on December 31, 2022.
- During the last 3 years, APEN annual EBITDA has fallen by -$12.57 million (-66.02%).
Performance
APEN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$7.57 M
+$1.78 M+19.04%
December 31, 2022
Summary
- As of February 10, 2025, APEN quarterly EBITDA is -$7.57 million, with the most recent change of +$1.78 million (+19.04%) on December 31, 2022.
- Over the past year, APEN quarterly EBITDA has dropped by -$2.14 million (-39.39%).
Performance
APEN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$31.62 M
-$2.14 M-7.26%
December 31, 2022
Summary
- As of February 10, 2025, APEN TTM EBITDA is -$31.62 million, with the most recent change of -$2.14 million (-7.26%) on December 31, 2022.
- Over the past year, APEN TTM EBITDA has dropped by -$18.64 million (-143.67%).
Performance
APEN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
APEN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -143.7% | -39.4% | -143.7% |
| 3 y3 years | -66.0% | -54.6% | -66.0% |
| 5 y5 years | -147.7% | -102.2% | -66.0% |
APEN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +143.7% | at low | +39.4% | +23.5% | +143.7% | at low |
| 5 y | 5-year | +143.7% | at low | +2423.3% | +23.5% | +593.5% | at low |
| alltime | all time | -1698.2% | +2.0% | -402.3% | +97.3% | -1283.5% | +2.0% |
Apollo Endosurgery EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$31.62 M(+143.7%) | -$7.57 M(-19.0%) | -$31.62 M(+7.3%) |
| Sep 2022 | - | -$9.35 M(+10.9%) | -$29.48 M(+19.8%) |
| Jun 2022 | - | -$8.43 M(+34.6%) | -$24.60 M(+45.1%) |
| Mar 2022 | - | -$6.26 M(+15.3%) | -$16.95 M(+30.7%) |
| Dec 2021 | -$12.98 M(-3.8%) | -$5.43 M(+21.4%) | -$12.98 M(+48.6%) |
| Sep 2021 | - | -$4.47 M(+469.1%) | -$8.73 M(+91.5%) |
| Jun 2021 | - | -$786.00 K(-65.6%) | -$4.56 M(-41.3%) |
| Mar 2021 | - | -$2.29 M(+92.6%) | -$7.76 M(-42.5%) |
| Dec 2020 | -$13.49 M(-29.2%) | -$1.19 M(+295.7%) | -$13.49 M(-21.6%) |
| Sep 2020 | - | -$300.00 K(-92.5%) | -$17.20 M(-26.2%) |
| Jun 2020 | - | -$3.99 M(-50.2%) | -$23.30 M(-11.6%) |
| Mar 2020 | - | -$8.01 M(+63.7%) | -$26.37 M(+38.5%) |
| Dec 2019 | -$19.05 M(-40.9%) | -$4.90 M(-23.5%) | -$19.05 M(-34.5%) |
| Sep 2019 | - | -$6.40 M(-9.3%) | -$29.08 M(+0.1%) |
| Jun 2019 | - | -$7.06 M(+922.8%) | -$29.07 M(+3.2%) |
| Mar 2019 | - | -$690.00 K(-95.4%) | -$28.17 M(-12.6%) |
| Dec 2018 | -$32.24 M(+152.6%) | -$14.93 M(+133.9%) | -$32.24 M(+53.2%) |
| Sep 2018 | - | -$6.38 M(+3.6%) | -$21.05 M(+30.6%) |
| Jun 2018 | - | -$6.17 M(+29.6%) | -$16.12 M(+21.9%) |
| Mar 2018 | - | -$4.76 M(+27.1%) | -$13.22 M(+3.7%) |
| Dec 2017 | -$12.76 M(-5.6%) | -$3.74 M(+158.0%) | -$12.75 M(-23.4%) |
| Sep 2017 | - | -$1.45 M(-55.6%) | -$16.64 M(-3.4%) |
| Jun 2017 | - | -$3.27 M(-23.7%) | -$17.22 M(+7.7%) |
| Mar 2017 | - | -$4.29 M(-43.8%) | -$15.99 M(+17.5%) |
| Dec 2016 | -$13.52 M(+30.1%) | -$7.63 M(+274.7%) | -$13.60 M(+67.8%) |
| Sep 2016 | - | -$2.04 M(+0.1%) | -$8.11 M(-0.9%) |
| Jun 2016 | - | -$2.03 M(+7.0%) | -$8.18 M(-12.5%) |
| Mar 2016 | - | -$1.90 M(-11.0%) | -$9.34 M(-10.1%) |
| Dec 2015 | -$10.39 M(-40.9%) | -$2.14 M(+1.4%) | -$10.39 M(-30.8%) |
| Sep 2015 | - | -$2.11 M(-34.1%) | -$15.02 M(-8.5%) |
| Jun 2015 | - | -$3.20 M(+8.4%) | -$16.41 M(-6.1%) |
| Mar 2015 | - | -$2.95 M(-56.3%) | -$17.48 M(-0.6%) |
| Dec 2014 | -$17.59 M(+137.8%) | -$6.76 M(+93.1%) | -$17.59 M(+33.3%) |
| Sep 2014 | - | -$3.50 M(-17.9%) | -$13.20 M(+15.3%) |
| Jun 2014 | - | -$4.26 M(+39.1%) | -$11.44 M(+26.8%) |
| Mar 2014 | - | -$3.06 M(+29.4%) | -$9.03 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$7.40 M(+37.6%) | -$2.37 M(+35.6%) | -$7.40 M(+8.5%) |
| Sep 2013 | - | -$1.75 M(-5.3%) | -$6.82 M(+6.6%) |
| Jun 2013 | - | -$1.84 M(+28.6%) | -$6.40 M(+14.1%) |
| Mar 2013 | - | -$1.43 M(-19.9%) | -$5.61 M(+4.3%) |
| Dec 2012 | -$5.37 M(+50.6%) | -$1.79 M(+35.0%) | -$5.37 M(-10.1%) |
| Sep 2012 | - | -$1.33 M(+25.8%) | -$5.98 M(+12.3%) |
| Jun 2012 | - | -$1.05 M(-12.4%) | -$5.33 M(+9.0%) |
| Mar 2012 | - | -$1.20 M(-49.8%) | -$4.89 M(+37.0%) |
| Dec 2011 | -$3.57 M(-17.5%) | -$2.40 M(+256.4%) | -$3.57 M(+60.9%) |
| Sep 2011 | - | -$672.40 K(+9.1%) | -$2.22 M(-15.0%) |
| Jun 2011 | - | -$616.50 K(-625.1%) | -$2.61 M(-44.3%) |
| Mar 2011 | - | $117.40 K(-111.2%) | -$4.68 M(+8.2%) |
| Dec 2010 | -$4.32 M(-318.5%) | -$1.05 M(-1.5%) | -$4.32 M(+21.5%) |
| Sep 2010 | - | -$1.06 M(-60.5%) | -$3.56 M(<-9900.0%) |
| Jun 2010 | - | -$2.69 M(-668.2%) | $7600.00(-99.7%) |
| Mar 2010 | - | $473.20 K(-268.3%) | $2.67 M(+35.0%) |
| Dec 2009 | $1.98 M(-117.2%) | -$281.10 K(-111.2%) | $1.98 M(+403.7%) |
| Sep 2009 | - | $2.50 M(<-9900.0%) | $392.80 K(-109.2%) |
| Jun 2009 | - | -$24.60 K(-88.8%) | -$4.25 M(-36.0%) |
| Mar 2009 | - | -$219.90 K(-88.2%) | -$6.64 M(-42.3%) |
| Dec 2008 | -$11.52 M(-24.8%) | -$1.87 M(-12.9%) | -$11.52 M(-17.6%) |
| Sep 2008 | - | -$2.14 M(-11.2%) | -$13.98 M(-15.4%) |
| Jun 2008 | - | -$2.41 M(-52.6%) | -$16.53 M(-6.7%) |
| Mar 2008 | - | -$5.10 M(+17.6%) | -$17.72 M(+15.7%) |
| Dec 2007 | -$15.32 M(+168.0%) | -$4.33 M(-7.6%) | -$15.32 M(+22.2%) |
| Sep 2007 | - | -$4.69 M(+30.1%) | -$12.53 M(+37.1%) |
| Jun 2007 | - | -$3.60 M(+33.8%) | -$9.14 M(+29.8%) |
| Mar 2007 | - | -$2.69 M(+74.2%) | -$7.04 M(+23.2%) |
| Dec 2006 | -$5.72 M(+146.1%) | -$1.55 M(+19.1%) | -$5.72 M(+2.7%) |
| Sep 2006 | - | -$1.30 M(-13.7%) | -$5.57 M(+14.9%) |
| Jun 2006 | - | -$1.50 M(+10.2%) | -$4.84 M(+34.4%) |
| Mar 2006 | - | -$1.37 M(-2.3%) | -$3.60 M(+55.1%) |
| Dec 2005 | -$2.32 M | -$1.40 M(+142.8%) | -$2.32 M(+151.2%) |
| Sep 2005 | - | -$575.90 K(+118.2%) | -$924.60 K(+165.2%) |
| Jun 2005 | - | -$263.90 K(+211.2%) | -$348.70 K(+311.2%) |
| Mar 2005 | - | -$84.80 K | -$84.80 K |
FAQ
- What is Apollo Endosurgery annual EBITDA?
- What is the all time high annual EBITDA for Apollo Endosurgery?
- What is Apollo Endosurgery annual EBITDA year-on-year change?
- What is Apollo Endosurgery quarterly EBITDA?
- What is the all time high quarterly EBITDA for Apollo Endosurgery?
- What is Apollo Endosurgery quarterly EBITDA year-on-year change?
- What is Apollo Endosurgery TTM EBITDA?
- What is the all time high TTM EBITDA for Apollo Endosurgery?
- What is Apollo Endosurgery TTM EBITDA year-on-year change?
What is Apollo Endosurgery annual EBITDA?
The current annual EBITDA of APEN is -$31.62 M
What is the all time high annual EBITDA for Apollo Endosurgery?
Apollo Endosurgery all-time high annual EBITDA is $1.98 M
What is Apollo Endosurgery annual EBITDA year-on-year change?
Over the past year, APEN annual EBITDA has changed by -$18.64 M (-143.67%)
What is Apollo Endosurgery quarterly EBITDA?
The current quarterly EBITDA of APEN is -$7.57 M
What is the all time high quarterly EBITDA for Apollo Endosurgery?
Apollo Endosurgery all-time high quarterly EBITDA is $2.50 M
What is Apollo Endosurgery quarterly EBITDA year-on-year change?
Over the past year, APEN quarterly EBITDA has changed by -$2.14 M (-39.39%)
What is Apollo Endosurgery TTM EBITDA?
The current TTM EBITDA of APEN is -$31.62 M
What is the all time high TTM EBITDA for Apollo Endosurgery?
Apollo Endosurgery all-time high TTM EBITDA is $2.67 M
What is Apollo Endosurgery TTM EBITDA year-on-year change?
Over the past year, APEN TTM EBITDA has changed by -$18.64 M (-143.67%)